Pranporn Kuropakornpong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pranporn Kuropakornpong has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Arunporn Itharat
Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Klongluang, Pathumthani 12120, Thailand
8 shared publications - Neal M. Davies
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2H1, Canada
6 shared publications - Sunita Makchuchit
Center of Excellence in Applied Thai Traditional Medicine Research (CEATMR), Thammasat University, Klongluang, Pathumthani 12120, Thailand
5 shared publications - Vilailak Tiyao
Center of Excellence in Applied Thai Traditional Medicine Research (CEATMR), Thammasat University, Klongluang, Pathumthani 12120, Thailand
3 shared publications - Weerachai Pipatrattanaseree
Regional Medical Science Center 12 Songkhla, Department of Medical Sciences, Ministry of Public Health, Songkhla, 90100, Thailand
3 shared publications - Chatchai Mingmalairak
Department of Surgery, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
2 shared publications
Latest Publications
- Open Access
- 20 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 8389
Botanical Substitution in Traditional ‘Rang Chuet’ Preparations: Distinguishing the Potential Xenobiotic Modulation of Thunbergia laurifolia Lindl. from the Hepatotoxic Risks of Crotalaria spectabilis Roth
Rang Chuet is a traditional Thai medicinal plant widely used for detoxification, although the name is applied to several botanically distinct species. This study investigated the ethnopharmacological basis and potential molecular mechanisms underlying this practice by integrating practitioner knowledge, botanical authentication, phytochemical profiling, and molecular docking. Structured interviews were conducted with 30 experienced traditional medicine practitioners from five regions of Thailand to document the therapeutic use and preparation of Rang Chuet. Botanical identification confirmed three species marketed under this name: Crotalaria spectabilis Roth, Curcuma rangjued Saensouk & Boonma, and Thunbergia laurifolia Lindl. Most practitioners used Rang Chuet primarily for detoxification, with C. spectabilis and T. laurifolia being the predominant species. LC–MS/MS analysis identified fifteen phytochemicals, including compounds common to both species, such as apigenin, quercetin, and caffeic acid, together with species-specific constituents including rosmarinic acid and α-spinasterol in T. laurifolia. Molecular docking suggested that selected phytochemicals may interact with xenobiotic-sensing receptors, with α-spinasterol showing favorable binding to the Pregnane X Receptor (PXR) and apigenin and catechin to the Aryl Hydrocarbon Receptor (AhR). However, C. spectabilis is a recognised source of hepatotoxic pyrrolizidine alkaloids, and because molecular docking cannot distinguish agonist from antagonist activity or establish functional receptor activation, these predicted interactions should not be interpreted as evidence of detoxification efficacy or safety. These findings provide a scientific framework linking traditional knowledge, botanical diversity, phytochemical composition, and potential receptor-mediated mechanisms, and highlight the public health risk of botanical substitution under the shared vernacular name “Rang Chuet.” These findings are hypothesis-generating and warrant future functional and toxicological validation, particularly regarding C. spectabilis.
- 20 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (18) , 8389
Open AccessBotanical Substitution in Traditional ‘Rang Chuet’ Preparations: Distinguishing the Potential Xenobiotic Modulation of Thunbergia laurifolia Lindl. from the Hepatotoxic Risks of Crotalaria spectabilis Roth
Rang Chuet is a traditional Thai medicinal plant widely used for detoxification, although the name is applied to several botanically distinct species. This study investigated the ethnopharmacological basis and potential molecular mechanisms underlying this practice by integrating practitioner knowledge, botanical authentication, phytochemical profiling, and molecular docking. Structured interviews were conducted with 30 experienced traditional medicine practitioners from five regions of Thailand to document the therapeutic use and preparation of Rang Chuet. Botanical identification confirmed three species marketed under this name: Crotalaria spectabilis Roth, Curcuma rangjued Saensouk & Boonma, and Thunbergia laurifolia Lindl. Most practitioners used Rang Chuet primarily for detoxification, with C. spectabilis and T. laurifolia being the predominant species. LC–MS/MS analysis identified fifteen phytochemicals, including compounds common to both species, such as apigenin, quercetin, and caffeic acid, together with species-specific constituents including rosmarinic acid and α-spinasterol in T. laurifolia. Molecular docking suggested that selected phytochemicals may interact with xenobiotic-sensing receptors, with α-spinasterol showing favorable binding to the Pregnane X Receptor (PXR) and apigenin and catechin to the Aryl Hydrocarbon Receptor (AhR). However, C. spectabilis is a recognised source of hepatotoxic pyrrolizidine alkaloids, and because molecular docking cannot distinguish agonist from antagonist activity or establish functional receptor activation, these predicted interactions should not be interpreted as evidence of detoxification efficacy or safety. These findings provide a scientific framework linking traditional knowledge, botanical diversity, phytochemical composition, and potential receptor-mediated mechanisms, and highlight the public health risk of botanical substitution under the shared vernacular name “Rang Chuet.” These findings are hypothesis-generating and warrant future functional and toxicological validation, particularly regarding C. spectabilis.
- Open Access
- 18 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7389
Serum Peptidomic Analysis in a Comparative Study of the Efficacy of Benjakul Remedy Versus Loratadine in Allergic Rhinitis Patients
Benjakul (BJK) remedy, traditionally used to balance the four elements, has demonstrated clinical efficacy in relieving inflammation and allergic rhinitis (AR) symptoms. This study investigated differential serum peptide expression in AR patients treated with BJK remedy compared to loratadine using MALDI-TOF MS and LC-MS/MS. MALDI-TOF MS revealed four shared mass peptide patterns that were significantly upregulated (p < 0.05) after 3 and 6 weeks of both treatments. Identifying the peptides, 17β-hydroxysteroid dehydrogenase (17β-HSD) and microtubule-actin cross-linking factor 1 (MACF1) were linked to inflammatory suppression and hormonal balance, while zinc finger CCCH-type containing 4 (ZC3H4) and transducin beta-like protein 3 (TBL3) were associated with the relief of pulmonary fibrosis. Conversely, zinc finger homeobox 3 (ZFHX3) and transformation/transcription domain-associated protein (TRRAP) remained elevated after treatment, potentially promoting persistent inflammation via E2F transcription factor 1- (E2F1-) and E2F transcription factor 4- (E2F4-) mediated transcription. Among 1113 peptides identified by LC-MS/MS (selected using a significance threshold of p < 0.05, without a fixed fold-change cutoff), 6-week treatment with BJK remedy significantly downregulated UBQLN1 (4.562-fold; p = 0.016), suppressing toll-like receptor (TLR) activation and B-cell proliferation. It also upregulated Prostaglandin E synthase 2 (PTGES2) and PDZ and LIM domain protein 2 (PDLIM2) (7.841-fold and 8.697-fold, respectively; p = 0.004 and 0.002), while enhancing antioxidant and immunoregulatory responses via ATP-binding cassette subfamily B member 8 (ABCB8) and ADP-ribosylation factor GTPase-activating protein 3 (ARFGAP3). By comparison, 3 weeks loratadine treatment significantly downregulated E2F transcription factor 3 (E2F3) and general transcription factor IIIC subunit 6 (GTF3C6) (p = 0.034 and 0.017) and upregulated CTD small phosphatase like 2 (CTDSPL2), suggesting a distinct but complementary anti-inflammatory mechanism. Together, these findings enhance the understanding of AR pathophysiology and may help to elucidate the mechanisms of BJK remedy and loratadine in treatment, supporting the further development of targeted therapies and biomarkers.
- 18 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7389
Open AccessSerum Peptidomic Analysis in a Comparative Study of the Efficacy of Benjakul Remedy Versus Loratadine in Allergic Rhinitis Patients
Benjakul (BJK) remedy, traditionally used to balance the four elements, has demonstrated clinical efficacy in relieving inflammation and allergic rhinitis (AR) symptoms. This study investigated differential serum peptide expression in AR patients treated with BJK remedy compared to loratadine using MALDI-TOF MS and LC-MS/MS. MALDI-TOF MS revealed four shared mass peptide patterns that were significantly upregulated (p < 0.05) after 3 and 6 weeks of both treatments. Identifying the peptides, 17β-hydroxysteroid dehydrogenase (17β-HSD) and microtubule-actin cross-linking factor 1 (MACF1) were linked to inflammatory suppression and hormonal balance, while zinc finger CCCH-type containing 4 (ZC3H4) and transducin beta-like protein 3 (TBL3) were associated with the relief of pulmonary fibrosis. Conversely, zinc finger homeobox 3 (ZFHX3) and transformation/transcription domain-associated protein (TRRAP) remained elevated after treatment, potentially promoting persistent inflammation via E2F transcription factor 1- (E2F1-) and E2F transcription factor 4- (E2F4-) mediated transcription. Among 1113 peptides identified by LC-MS/MS (selected using a significance threshold of p < 0.05, without a fixed fold-change cutoff), 6-week treatment with BJK remedy significantly downregulated UBQLN1 (4.562-fold; p = 0.016), suppressing toll-like receptor (TLR) activation and B-cell proliferation. It also upregulated Prostaglandin E synthase 2 (PTGES2) and PDZ and LIM domain protein 2 (PDLIM2) (7.841-fold and 8.697-fold, respectively; p = 0.004 and 0.002), while enhancing antioxidant and immunoregulatory responses via ATP-binding cassette subfamily B member 8 (ABCB8) and ADP-ribosylation factor GTPase-activating protein 3 (ARFGAP3). By comparison, 3 weeks loratadine treatment significantly downregulated E2F transcription factor 3 (E2F3) and general transcription factor IIIC subunit 6 (GTF3C6) (p = 0.034 and 0.017) and upregulated CTD small phosphatase like 2 (CTDSPL2), suggesting a distinct but complementary anti-inflammatory mechanism. Together, these findings enhance the understanding of AR pathophysiology and may help to elucidate the mechanisms of BJK remedy and loratadine in treatment, supporting the further development of targeted therapies and biomarkers.
- Open Access
- 13 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7239
Cytotoxic and Anti-Inflammatory Evaluation of Thai Medicinal Plants from Kampramong’s Anticancer Remedy Against Upper Respiratory Tract Malignancies
Field cancerization in the upper respiratory tract (URT) heavily drives cancer recurrence. The present study evaluated Thai ethnobotanical ingredients from Kampramong’s anticancer remedies as alternative agents for URT cancer control. Thirty-one ethanolic extracts were screened for cytotoxicity against six URT malignant cell lines (HK1, KB, HONE-1, NPC38, NPC43, and HEp2) and two non-cancerous controls (NP460 and HaCaT) using the sulforhodamine B (SRB) assay. The selectivity index or IC50 ratio of normal cells/cancer cells was also determined for selective cytotoxicity of extracts and compounds. Anti-inflammatory activity was measured using the nitric oxide (NO) reduction assay. Antioxidant capacity was measured using the DPPH radical scavenging assay. Total flavonoid content (TFC) was measured due to the main risk reduction factor. Multivariate analyses (Hierarchical Cluster Analysis; HCA and Principal Component Analysis; PCA) were used for the relationship of flavonoids, NO inhibition drive to cytotoxicity. The best plant extracts and their cytotoxic compounds were also predicted to have their target molecular mechanisms by molecular docking. HCA identified Caesalpinia sappan, Coscinium fenestratum, and Tectona grandis as exhibiting potent cytotoxicity against all malignant cells, with C. sappan being the most potent. PCA revealed that flavonoid content and nitric oxide inhibition were the critical factors driving cytotoxicity (factor load 71.93%). Molecular docking of C. sappan compounds, brazilin and sappanchalcone, showed high binding energies with multiple core target proteins (MAPK1, MAPK3, SRC, AKT1, and GRB2), indicating a synergistic multi-compound, multi-target mechanism, representing a hypothesis for future mechanistic validation. Kampramong’s ethnobotanical remedies, particularly C. sappan, are promising candidates for URT malignancy treatment and field cancerization prevention, offering valuable data for future drug development.
- 13 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7239
Open AccessCytotoxic and Anti-Inflammatory Evaluation of Thai Medicinal Plants from Kampramong’s Anticancer Remedy Against Upper Respiratory Tract Malignancies
Field cancerization in the upper respiratory tract (URT) heavily drives cancer recurrence. The present study evaluated Thai ethnobotanical ingredients from Kampramong’s anticancer remedies as alternative agents for URT cancer control. Thirty-one ethanolic extracts were screened for cytotoxicity against six URT malignant cell lines (HK1, KB, HONE-1, NPC38, NPC43, and HEp2) and two non-cancerous controls (NP460 and HaCaT) using the sulforhodamine B (SRB) assay. The selectivity index or IC50 ratio of normal cells/cancer cells was also determined for selective cytotoxicity of extracts and compounds. Anti-inflammatory activity was measured using the nitric oxide (NO) reduction assay. Antioxidant capacity was measured using the DPPH radical scavenging assay. Total flavonoid content (TFC) was measured due to the main risk reduction factor. Multivariate analyses (Hierarchical Cluster Analysis; HCA and Principal Component Analysis; PCA) were used for the relationship of flavonoids, NO inhibition drive to cytotoxicity. The best plant extracts and their cytotoxic compounds were also predicted to have their target molecular mechanisms by molecular docking. HCA identified Caesalpinia sappan, Coscinium fenestratum, and Tectona grandis as exhibiting potent cytotoxicity against all malignant cells, with C. sappan being the most potent. PCA revealed that flavonoid content and nitric oxide inhibition were the critical factors driving cytotoxicity (factor load 71.93%). Molecular docking of C. sappan compounds, brazilin and sappanchalcone, showed high binding energies with multiple core target proteins (MAPK1, MAPK3, SRC, AKT1, and GRB2), indicating a synergistic multi-compound, multi-target mechanism, representing a hypothesis for future mechanistic validation. Kampramong’s ethnobotanical remedies, particularly C. sappan, are promising candidates for URT malignancy treatment and field cancerization prevention, offering valuable data for future drug development.
- Open Access
- 5 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 7031
Acute and Chronic Toxicity Tests and Assessment of In Vitro and In Vivo Anti-Allergic Effects of Prabchompoothaweep Remedy
Prabchompoothaweep (PCT) is an anti-allergic remedy on the Thailand National List of Essential Medicines, traditionally used to relieve common colds and allergic reactions in Thai traditional medicine (TTM). However, the anti-allergic activity of PCT and its plant ingredients had not been characterized. We evaluated the acute and chronic oral toxicity of PCT ethanolic extract in rats and assessed its in vitro and in vivo anti-allergic activities. Activity in vitro was measured as inhibition of antigen-induced β-hexosaminidase release in RBL-2H3 cells and in vivo using an ovalbumin (OVA)-induced allergic rhinitis mouse model. The extract produced no mortality or signs of toxicity in either study. Several plant ingredients and the PCT extract inhibited β-hexosaminidase release more effectively than chlorpheniramine. In OVA-induced mice, PCT (75, 150, and 300 mg/kg) did not significantly lower OVA-specific serum IgE or IgG2a (OVA-specific IgG1 was likewise not reduced); however, it reduced inflammatory cell infiltration, goblet cell hyperplasia and mast cell numbers in the nasal mucosa and downregulated the T helper 2 (Th2) cytokines IL-5 and IL-13. These findings support the traditional anti-allergic use of the PCT remedy.
- 5 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 7031
Open AccessAcute and Chronic Toxicity Tests and Assessment of In Vitro and In Vivo Anti-Allergic Effects of Prabchompoothaweep Remedy
Prabchompoothaweep (PCT) is an anti-allergic remedy on the Thailand National List of Essential Medicines, traditionally used to relieve common colds and allergic reactions in Thai traditional medicine (TTM). However, the anti-allergic activity of PCT and its plant ingredients had not been characterized. We evaluated the acute and chronic oral toxicity of PCT ethanolic extract in rats and assessed its in vitro and in vivo anti-allergic activities. Activity in vitro was measured as inhibition of antigen-induced β-hexosaminidase release in RBL-2H3 cells and in vivo using an ovalbumin (OVA)-induced allergic rhinitis mouse model. The extract produced no mortality or signs of toxicity in either study. Several plant ingredients and the PCT extract inhibited β-hexosaminidase release more effectively than chlorpheniramine. In OVA-induced mice, PCT (75, 150, and 300 mg/kg) did not significantly lower OVA-specific serum IgE or IgG2a (OVA-specific IgG1 was likewise not reduced); however, it reduced inflammatory cell infiltration, goblet cell hyperplasia and mast cell numbers in the nasal mucosa and downregulated the T helper 2 (Th2) cytokines IL-5 and IL-13. These findings support the traditional anti-allergic use of the PCT remedy.
- Open Access
- 1 September 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (5) , 1451-1473
Exploring traditional uses and biological activities related to liver cancer of Saban remedy extracts for potential liver cancer treatment
Context: Saban remedy is used at Khampramong Temple to relieve adverse effects in liver cancer patients. Aims: To analyze the taste and biological activities of Saban remedy and Cassia garrettiana as a principal component species in liver cancer treatment supported in vitro and in vivo. Methods: Saban remedy and its ingredient extracts were tested for cytotoxic activity against hepatocellular carcinoma (HepG2, KKU-M156), cholangiocarcinoma cells, and normal human lung fibroblast cells (MRC-5) using the sulforhodamine B assay. Anti-inflammatory effects were evaluated through inhibition of inflammatory cytokine production (RAW 264.7 cell line), and mutagenicity and anti-mutagenicity were assessed using the Salmonella typhimurium strain TA98 and TA100 mutation assay. Both Saban remedy extracts and ethanolic C. garrettiana extract were tested in vivo for anti-hepatocarcinogenesis during the initiation stage in male Wistar rats. Results: Saban remedy, traditionally used as a purgative, exhibited bitter and bitter-nauseating flavors. The remedy demonstrated in vitro cytotoxic activity and in vivo reduction of GST-P foci in liver tissue, indicating protective and therapeutic potential against liver cancer. Saban remedy ethanolic extracts showed significant anti-inflammatory effects through nitric oxide inhibition. Notably, the aqueous extract of Saban remedy effectively reduced GST-P foci, a preneoplastic liver lesion, though it exhibited fewer biological activities compared to the ethanolic extract. This aligns with Khampramong Temple’s clinical use of the aqueous solution in cancer patients. Conclusions: The taste and biological properties of Saban remedy are correlated, supporting its use in treating liver cancer through various bioactivities.
- 1 September 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (5) , 1451-1473
Open AccessExploring traditional uses and biological activities related to liver cancer of Saban remedy extracts for potential liver cancer treatment
Context: Saban remedy is used at Khampramong Temple to relieve adverse effects in liver cancer patients. Aims: To analyze the taste and biological activities of Saban remedy and Cassia garrettiana as a principal component species in liver cancer treatment supported in vitro and in vivo. Methods: Saban remedy and its ingredient extracts were tested for cytotoxic activity against hepatocellular carcinoma (HepG2, KKU-M156), cholangiocarcinoma cells, and normal human lung fibroblast cells (MRC-5) using the sulforhodamine B assay. Anti-inflammatory effects were evaluated through inhibition of inflammatory cytokine production (RAW 264.7 cell line), and mutagenicity and anti-mutagenicity were assessed using the Salmonella typhimurium strain TA98 and TA100 mutation assay. Both Saban remedy extracts and ethanolic C. garrettiana extract were tested in vivo for anti-hepatocarcinogenesis during the initiation stage in male Wistar rats. Results: Saban remedy, traditionally used as a purgative, exhibited bitter and bitter-nauseating flavors. The remedy demonstrated in vitro cytotoxic activity and in vivo reduction of GST-P foci in liver tissue, indicating protective and therapeutic potential against liver cancer. Saban remedy ethanolic extracts showed significant anti-inflammatory effects through nitric oxide inhibition. Notably, the aqueous extract of Saban remedy effectively reduced GST-P foci, a preneoplastic liver lesion, though it exhibited fewer biological activities compared to the ethanolic extract. This aligns with Khampramong Temple’s clinical use of the aqueous solution in cancer patients. Conclusions: The taste and biological properties of Saban remedy are correlated, supporting its use in treating liver cancer through various bioactivities.
- Open Access
- 5 May 2025
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 91, 103185
Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial
- 5 May 2025
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 91, 103185
Open AccessEfficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial
- 1 April 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 287, 114932
Ethnopharmacological nexus between the traditional Thai medicine theory and biologically based cancer treatment
- 1 April 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 287, 114932
Ethnopharmacological nexus between the traditional Thai medicine theory and biologically based cancer treatment
- 24 October 2017
- Published by Georg Thieme Verlag KG
- Vol. 4 (S 01) , Tu-PO-83
Cytotoxic activity of medicinal plants selected from Euphorbiaceae family against Hepatocellular carcinoma cell
Euphorbiaceae is the large flowering plant families. A variety of Euphorbiaceae-based phytochemicals including alkaloids, flavonoids, saponins, tannins, phenols and essential oils, it would appear that their diverse medicinal properties. In this study we investigated the cytotoxic activity of the selected medicinal plants from Euphorbiaceae family against hepatocellular carcinoma cell line (HepG2) by using sulphorhodamine B (SRB) assay. The aqueous and ethanolic extract from Ricinus communis Linn, Jatropha multifida Linn, Euphorbia antiquorum Linn, Trigonostemon reidioides (Kurz) Craib and Bridelia ovata Decne. were tested for screen their cytotoxic activity against HepG2. The results found that only 3 ethanolic extracts with potent cytotoxic activity (IC50 < 50 µg/ml). The ethanolic extract of T. reidioides showed the highest cytotoxic activity against HepG2 which IC50 of 0.016 ± 0.002 µg/ml following by E. antiquorum 0.43 ± 0.02 µg/ml. And the ethanolic extract of J. multifida showed less cytotoxic activity against HepG2 which IC50 of 26.20 ± 1.15 µg/ml. In conclusion, this study obtained the potent natural source for anti-liver cancer from T. reidioides and E. antiquorum. It should be continuously isolate cytotoxic compounds from this plant.
- 24 October 2017
- Published by Georg Thieme Verlag KG
- Vol. 4 (S 01) , Tu-PO-83
Cytotoxic activity of medicinal plants selected from Euphorbiaceae family against Hepatocellular carcinoma cell
Euphorbiaceae is the large flowering plant families. A variety of Euphorbiaceae-based phytochemicals including alkaloids, flavonoids, saponins, tannins, phenols and essential oils, it would appear that their diverse medicinal properties. In this study we investigated the cytotoxic activity of the selected medicinal plants from Euphorbiaceae family against hepatocellular carcinoma cell line (HepG2) by using sulphorhodamine B (SRB) assay. The aqueous and ethanolic extract from Ricinus communis Linn, Jatropha multifida Linn, Euphorbia antiquorum Linn, Trigonostemon reidioides (Kurz) Craib and Bridelia ovata Decne. were tested for screen their cytotoxic activity against HepG2. The results found that only 3 ethanolic extracts with potent cytotoxic activity (IC50 < 50 µg/ml). The ethanolic extract of T. reidioides showed the highest cytotoxic activity against HepG2 which IC50 of 0.016 ± 0.002 µg/ml following by E. antiquorum 0.43 ± 0.02 µg/ml. And the ethanolic extract of J. multifida showed less cytotoxic activity against HepG2 which IC50 of 26.20 ± 1.15 µg/ml. In conclusion, this study obtained the potent natural source for anti-liver cancer from T. reidioides and E. antiquorum. It should be continuously isolate cytotoxic compounds from this plant.